Infection Surveillance Solutions Market: Challenges and Opportunities
The global Infection Surveillance Solutions Market is projected to reach USD 1,100 million by 2027 from USD 577 million in 2022, at a CAGR of 13.8% during the forecast period. Growth in this market is predominantly driven by the increasing prevalence of hospital-acquired infections and new Medicare policies, including non-payment for hospital-acquired conditions. The rising number of surgeries, the growing geriatric population, the increasing incidence of chronic diseases, and increasing adoption of antimicrobial stewardship programs are the other factors driving the growth of this market. However, data breaches, and lack of skilled analysts are expected to hamper the growth of this market during the forecast period to a certain extent.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=21857517
Opportunities: Emerging Markets
The
infection surveillance solutions market is expected to experience
significant growth opportunities in countries with emerging economies
such as India, China, Brazil, Russia, and countries in Latin America and
Southeast Asia. This is due to the fact that these regions are home to a
large portion of the world's population, with over half residing in
India and China. Additionally, factors such as public demand for better
quality hospital care, the rise in costs associated with
healthcare-associated infections (HAIs), the emergence of
multi-drug-resistant microorganisms, and government initiatives are
contributing to the growth of the market in these countries.
With
the growth in per capita income, increasing healthcare awareness, a
growing number of hospitals and clinics, and a vast patient population,
the demand for better healthcare services has increased in these
countries. Also, emerging economies in the APAC present lucrative
investment opportunities for multinational healthcare IT companies to
offshore their business operations to these markets. Expansions in
emerging markets are driving the adoption of infection control
technologies in the medical device manufacturing industry in these
countries, thereby providing opportunities for market growth.
Challenges: Data security concerns
The
growing reliance on networking and automated technologies (EHR) and the
shifting trend toward healthcare integration and health information
exchanges have helped expand the healthcare privacy and security
landscape. The electronic exchange of patient data offers greater reach
and efficiency in healthcare delivery; however, issues related to data
loss and liability due to broader access are associated with the
electronic exchange of patient data.
Wide patient information
exchanges lead to privacy and security risks and increase the chances of
data breaches. In healthcare, approximately one-third of data breaches
result in medical identity theft, mainly due to a lack of internal
control over patient information, outdated policies, procedures (or
nonadherence to existing ones), and inadequate personnel training. In
the US, the Identity Theft Resource Center reported that the healthcare
industry had the second-largest number of data breaches in 2019, along
with the highest exposure rate per breach.
Data collected from
various sources are transferred or directly entered into infection
surveillance platforms. Creating a secure communication platform is a
major challenge faced by healthcare IT vendors catering to the
healthcare industry. Potential security concerns related to HCIT systems
in healthcare organizations may lead to a sense of insecurity among
users, restraining the adoption of HCIT solutions, including infection
surveillance solutions, across the globe.
Request Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=21857517
Asia
Pacific region is expected to register the highest CAGR in the
infection surveillance solutions market during the forecast period
The
Asia Pacific market is expected to witness the highest growth from 2022
to 2027. There is a growing need to implement and integrate medical
devices and HCIT solutions in Asia to provide patients with
cost-effective and quality clinical care. As a result, many global HCIT
companies are investing in the Asian market to capitalize on the growing
opportunities. The growing patient volume and the rising need for
accurate and timely tracking and monitoring of diseases will fuel the
growth of the infection surveillance solutions market in Asia Pacific.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
Comments
Post a Comment